Equities in Canada’s largest market made their way skyward Tuesday, as resource and industrial issues powered the rise. The TSX jumped 193.88 points to finish Tuesday at 33,970.38. The Canadian dollar ...

Risk aversion sentiment weighing on Loonie - Trump speech and Fed speakers in the spotlight today - US dollar trading with a ...

Equities in Canada's largest centre rose on Tuesday, as gains in industrial and technology stocks offset losses in gold miners and financials. The TSX recovered 46.27 points to pause for lunch Tuesday ...

Hit a new 52-Week High of $22.30. Couloir Capital announced Tuesday that it has updated its research coverage on Almonty.

Another brutal day gripped Wall Street stocks on Monday. The Dow lost over 800 points after re-pricing the impact of the Supreme Court’s ruling against tariffs. PCE inflation, along with weak GDP data ...

Announced a strategic initiative to align emerging quantum computing technologies with its AgentNLP Enterprise Conversational AI platform. The initiative is designed to enhance processing speed, ...

Bitcoin’s (BTC-USD) extended decline is not unusual. The leading cryptocurrency has a history of steep decline, only to unexpectedly rebound to past highs. Bitcoin traded in the $68,000 range, ...

Space, Inc. (NASDAQ: ZSPC) began trading Tuesday slightly higher The San Jose-based company, a leading provider of augmented and virtual reality (AR/VR) solutions for education, today announced a ...

Dividend-income investors require holding companies that grow their payout and business. Two companies do not offer those ...

Cheniere Energy, Inc. (NYSE: LNG) shares collapsed in price Tuesday, as the company today celebrates the 10th anniversary of its first export cargo of liquefied natural gas. On16, Cheniere loaded the ...

Sunrun (NASDAQ: RUN) saw its shares poke ahead Tuesday. The company, which calls itself America’s largest provider of home battery storage, solar, and home-to-grid power plants, has completed a ...

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, Baystreet.ca News Commentary, The global oncology and cancer drugs market, valued at $167 billion in 2023, is projected to reach $335.2 billion ...